Skip to content

Evaluation of Propofol versus Etomidate for conscious sedation in adults endocopy

Propofol vs. Etomidate for Conscious Sedation in Upper GI Endoscopy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240208060940N1
Enrollment
200
Registered
2025-05-26
Start date
2023-03-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients undergoing GI endoscopy.

Interventions

Intervention 1: Etomidate is a short-acting intravenous anesthetic commonly used for sedation induction in short procedures such as endoscopy. It is preferred for its better hemodynamic stability, esp

Sponsors

Artesh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients over 18 years old undergoing an elective GI endoscopy having an ASA Class I or II.

Exclusion criteria

Exclusion criteria: history of allergy to propofol or etomidate an emergency nature of the procedure patients requiring deeper anesthesia/sedation like patients who needed tracheal intubation were excluded.

Design outcomes

Primary

MeasureTime frame
Proceduralist Satisfaction. Timepoint: At the end of the procedure. Method of measurement: Inquiry from Proceduralist(Endoscopist) and recording in researcher-developed forms.;Patient Satisfaction. Timepoint: At the end of the procedure. Method of measurement: Inquiry from the Patient and Recording as dichotomous outcome in researcher developed forms.

Secondary

MeasureTime frame
"procedure length". Timepoint: The beginning to the end of the procedure(endoscopy). Method of measurement: It is the elapsed time from the start to the end of the endoscopy, which was measured by a timer and recorded in study forms.;Adverse effects of anesthetic agent. Timepoint: at the end of the procedure. Method of measurement: inquiry from the patient based on a list of possible adverse events as well as open questions regarding adverse events outside the list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Jazayeri

Artesh University of Medical Sciences

nazanin.jazayeri@gmail.com021-86096350-5

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026